- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Intelgenx Technologies Corp
+ Add to WatchlistIGXT:US
0.6199 USD 0.0399 6.88%As of 20:10:00 ET on 05/17/2013.
Snapshot for Intelgenx Technologies Corp (IGXT)
| Open: | 0.5910 | Day's Range: | 0.5910 - 0.6199 | Volume: | 111,132 |
|---|---|---|---|---|---|
| Previous Close: | 0.5800 | 52wk Range: | 0.4500 - 0.7500 | 1-Yr Rtn: | +24.60% |
Key Statistics for IGXT
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0370 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 31.80 |
| Shares Outstanding (M) | 51.30 |
| 30 Day Average Volume | 187,662 |
| Price/Book (mrq) | 12.3584 |
| Price/Sale (ttm) | 23.8342 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IGXT
Company Profile & Key Executives for IGXT
IntelGenx Technologies Corporation develops pharmaceutical products. The Company seeks to establish contracts with pharmaceutical companies.
| Horst G ZerbeChairman/President/CEO | Paul A SimmonsChief Financial Officer |
| Rajiv KhoslaCOO/Chief Scientific Officer | Ingrid ZerbeDir:Fin & Admin/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IGXT News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page